Clopidogrel: The Data, the Experience, and the Controversies

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.6, 2012-12, pp. : 361-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience

Current Drug Targets, Vol. 14, Iss. 6, 2013-06 ,pp. : 637-643

Bentham Science Publishers

Access to resources Recommend Favorite

The safety of clopidogrel

By Mangalpally Kiran Kumar R Kleiman Neal S

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 85-95

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Clopidogrel

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5309-5327

Bentham Science Publishers

Access to resources Recommend Favorite

In the wake of recent study data, the UK MHRA has issued interim advice regarding concomitant use of clopidogrel and proton pump inhibitors

Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

In light of recent study data, the Irish Medicines Board has issued interim advice on concurrent use of clopidogrel and proton pump inhibitors

Reactions Weekly, Vol. 1, Iss. 1253, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite